APA (7th ed.) Citation

Liu, L., Wang, L., Zhao, J., Yu, X., Wu, Y., Su, C., & Chen, J. Aumolertinib in combination with Lastet in the first-line treatment of EGFR-mutated, locally advanced or metastatic non-small cell lung cancer (EVOLUTION): Protocol for a single-arm, phase II clinical trial. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Liu, Li, Li Wang, Jing Zhao, Xin Yu, Yan Wu, Chunxia Su, and Jianing Chen. Aumolertinib in Combination with Lastet in the First-line Treatment of EGFR-mutated, Locally Advanced or Metastatic Non-small Cell Lung Cancer (EVOLUTION): Protocol for a Single-arm, Phase II Clinical Trial. BMJ Publishing Group.

MLA (9th ed.) Citation

Liu, Li, et al. Aumolertinib in Combination with Lastet in the First-line Treatment of EGFR-mutated, Locally Advanced or Metastatic Non-small Cell Lung Cancer (EVOLUTION): Protocol for a Single-arm, Phase II Clinical Trial. BMJ Publishing Group.